(1) Background: Surgical site infections (SSIs) pose a significant clinical challenge, with early detection hindered by the overlap between physiological postoperative inflammation and incipient infection. Continuous wound temperature monitoring offers a promising, non-invasive method to identify subtle thermal deviations that precede overt clinical signs. This review synthesizes current evidence on the utility of temperature monitoring as an early predictor of SSI and evaluates its clinical applications. (2) Methods: A narrative literature review was conducted using PubMed and Embase for English-language studies published between 2015 and 2025. Following PRISMA principles, eligible studies were selected that examined continuous or repeated local wound temperature measurements in adult postoperative patients and their association with a clinical diagnosis of SSI. (3) Results: Six studies met the inclusion criteria. Key findings indicate that infected wounds may paradoxically exhibit lower temperatures “cold spots” than non-infected wounds in the early postoperative period. Dynamic indicators, particularly the temperature difference (ΔT) between the wound and adjacent skin and the temperature trajectory over time, proved more predictive than single, isolated measurements. Confounding factors such as patient adiposity were noted to influence thermal signatures. (4) Conclusions: Wound temperature monitoring is a valuable strategy for the early risk stratification of SSI. The analysis of thermal trends and dynamic parameters holds greater diagnostic significance than single readings. Integration with other biomarkers may further enhance specificity, but the development of standardized measurement protocols is essential for reliable clinical implementation and improved postoperative outcomes.

Surgical wound complications, particularly surgical site infection (SSI), remain common despite advances in perioperative care, and modern dressings—including emerging smart systems—are intended to optimize moisture balance, reduce bioburden, and support monitoring of healing. This narrative review, informed by PRISMA 2020, synthesized comparative clinical evidence on postoperative dressings across surgical specialties. PubMed and Embase were searched for peer-reviewed comparative human studies published in 2015–2025 involving adults undergoing surgery with primary closure or secondary intention healing. Outcomes included SSI, time to epithelialization/closure, scar outcomes, pain, peri-wound skin integrity, and dressing change frequency. Nine studies met the inclusion criteria across orthopedics, general and endocrine surgery, otolaryngology, maxillofacial surgery, and surgical oncology. In hip/knee arthroplasty, hydrofiber dressings were associated with lower SSI rates versus standard/absorbent dressings. A meta-analysis suggested that moist and silver-based dressings generally outperformed gauze, with ionic silver ranking highest for healing and metallic silver for SSI prevention, and hydrocolloids reduced dressing change frequency. Oxygen diffusion therapy improved scar outcomes after cervicotomy, and chitosan gel reduced synechiae after endoscopic sinus surgery. Evidence in oncologic surgery was inconclusive, and heterogeneity in interventions, endpoints, and follow-up limited pooling. Overall, advanced postoperative dressings may improve selected outcomes compared with traditional gauze, but effects appear procedure- and context-dependent; future studies should standardize outcomes, extend follow-up, and incorporate cost-effectiveness and patient-reported measures, alongside evaluation of sensor-enabled smart dressings.

Introduction: Arterial hypertension remains one of the leading risk factors for cardiovascular morbidity and mortality worldwide. Regular physical activity and lifestyle modification are considered essential components of hypertension management alongside pharmacological treatment. This study aimed to evaluate the impact of physical activity and cardiac rehabilitation on blood pressure control, health behaviors, and the effectiveness of pharmacological treatment in patients with arterial hypertension. Material and methods: The study included 70 patients with arterial hypertension (59% women, 41% men), divided into two age groups: 45–59 and ≥60 years. Conducted at the Municipal Hospital in Bielsko-Biała between May and November 2023, the study used a 36-question survey assessing physical activity, treatment, and anthropometric data. Statistical analysis included ANOVA and Tukey’s HSD test, with significance set at p < 0.05. Results: No significant differences were observed in systolic blood pressure reduction between groups (p = 0.666). Significant differences were found for diastolic blood pressure reduction (p = 0.003; η² = 0.22), with the greatest reduction observed in patients aged 45–59 years combining pharmacotherapy with regular physical activity (5.79 ± 3.22 mmHg). Physically active participants also reported healthier lifestyle behaviors and lower pharmacological burden more frequently. Conclusions: Regular physical activity was associated with improved diastolic blood pressure control and healthier lifestyle behaviors in hypertensive patients, particularly among younger individuals combining exercise with pharmacotherapy. Further large prospective studies are required to confirm these findings.

Inadvertent perioperative hypothermia increases susceptibility to surgical site infection (SSI) through impaired immune function, reduced oxidative killing, and altered collagen deposition. We performed a narrative review of recent clinical and translational studies evaluating active thermal management for SSI prevention, with emphasis on forced-air warming (FAW) and conductive systems, and on high-risk settings (prolonged surgery, elevated BMI, and pediatric patients). Across studies, active warming more reliably maintains intraoperative normothermia than passive insulation; however, evidence for a consistent reduction in SSI rates is strongest in vulnerable cohorts and lengthy procedures and remains heterogeneous across specialties. FAW demonstrates high warming efficiency, yet its use in implant-based operations continues to be debated because of potential airflow disruption and bacterial mobilization concerns. The literature increasingly supports precision approaches, including pre-warming protocols, improved perioperative temperature monitoring, and predictive models to identify patients at greatest risk of hypothermia. In conclusion, effective SSI prevention requires procedure- and patient-specific thermal strategies, selecting devices that balance warming performance with sterility considerations while integrating perioperative risk stratification and real-time monitoring.

Body temperature is a key vital sign, but traditional intermittent monitoring in hospitals increases nursing workload. Continuous monitoring via wearable sensors could improve efficiency and early deterioration detection, but systematic evidence remains scarce. This study therefore aimed to evaluate the clinical application of the SteadyTemp® and TempTraq® wireless temperature sensors for integration into clinical care protocols. A narrative review of the literature (PubMed/Embase, 2020–2025) including 58 clinical studies was conducted. The systems were compared in terms of accuracy, battery life, patient comfort, data security, and integration with hospital information systems/electronic medical records. Statistical analysis included means, standard deviations, and trend analysis. Both systems demonstrated clinical utility but differed in application. SteadyTemp® offers stable 7-day monitoring and GDPR-compliant data integration, suiting hospital use. TempTraq® provides high real-time accuracy (measurements every 10 s), benefiting paediatrics, but has a shorter 72-hour lifespan and higher cost. Wireless sensors are a valuable complement to traditional methods, enabling continuous, automated monitoring. SteadyTemp® is optimal for hospital settings, while TempTraq® is ideal for short-term paediatric fever detection, improving workflow and supporting early infection detection.

Primary pulmonary sarcomas are exceptionally rare, and pulmonary spindle cell sarcomas represent an even rarer, highly aggressive subset. Their clinical presentation is often nonspecific, and rapid local invasion may culminate in malignant spinal cord compression (MSCC), posing urgent diagnostic and therapeutic challenges. A 60-year-old man with a history of follicular lymphoma treated with O-CHOP and obinutuzumab maintenance subsequently developed a metachronous undifferentiated spindle cell sarcoma of the right upper lobe with pleural dissemination (FNCLCC grade 2). Despite multimodal therapy including cisplatin/etoposide and thoracic radiotherapy, followed by ifosfamide-imaging in June 2025 demonstrated rapid progression. Right-sided video-assisted thoracoscopic surgery revealed a massive, unresectable tumor infiltrating the chest wall. A subsequent gemcitabine/docetaxel regimen was initiated; shortly thereafter, the patient developed acute urinary retention and rapidly progressive lower-limb sensory symptoms evolving to paraparesis. Computed tomography showed a 127 × 99 × 165 mm right upper-lobe mass with osseous invasion and intraspinal extension at Th4–Th6 and Th11–Th12, with additional liver and bilateral renal metastases. Laboratory testing demonstrated severe anemia, thrombocytopenia, and markedly elevated inflammatory markers. Management included transfusion support, high-dose corticosteroids, antibiotics for MRSE urinary infection, and opioid-based analgesia. Given disseminated disease and ECOG 4 performance status, neurosurgical decompression and further systemic therapy were withheld, and the patient was discharged to home hospice. Abrupt neurological deterioration in aggressive thoracic sarcoma mandates urgent evaluation for MSCC; in terminal disseminated disease, early goal-concordant palliative care is essential.